Prevention and treatment of aspiration pneumonia in intensive care units.

Thibaud d'Escrivan, Benoit Guery
{"title":"Prevention and treatment of aspiration pneumonia in intensive care units.","authors":"Thibaud d'Escrivan,&nbsp;Benoit Guery","doi":"10.2165/00151829-200504050-00003","DOIUrl":null,"url":null,"abstract":"<p><p>Aspiration is a leading cause of nosocomial infection in the intensive care unit. Techniques to avoid or reduce aspiration are important in preventing pneumonia and pneumonitis. The most important preventive measures include the semi-recumbent position, the surveillance of enteral feeding, the use of promotility agents, and avoiding excessive sedation. The analysis of the pathogens involved in these syndromes usually shows a minor role for the anerobes. With regard to treatment, aspiration pneumonitis does not require any antimicrobials; on the contrary, aspiration pneumonia has to be treated. Empiric antimicrobials treatment should be started on clinical suspicion. The choice of the drug has to be guided by local pathogen epidemiology and clinical features; in fact, community type pneumonia requires a first-line antimicrobial such as amoxicillin/clavulanic acid. On the contrary, a nosocomial type of infection needs to be treated as a ventilator-associated pneumonia in agreement with published guidelines. Nevertheless, quantitative culture should be obtained in order to de-escalate antimicrobials. In conclusion, aspiration pneumonia is a frequently encountered disease that can be prevented by relatively simple measures.</p>","PeriodicalId":87162,"journal":{"name":"Treatments in respiratory medicine","volume":"4 5","pages":"317-24"},"PeriodicalIF":0.0000,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2165/00151829-200504050-00003","citationCount":"16","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Treatments in respiratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2165/00151829-200504050-00003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 16

Abstract

Aspiration is a leading cause of nosocomial infection in the intensive care unit. Techniques to avoid or reduce aspiration are important in preventing pneumonia and pneumonitis. The most important preventive measures include the semi-recumbent position, the surveillance of enteral feeding, the use of promotility agents, and avoiding excessive sedation. The analysis of the pathogens involved in these syndromes usually shows a minor role for the anerobes. With regard to treatment, aspiration pneumonitis does not require any antimicrobials; on the contrary, aspiration pneumonia has to be treated. Empiric antimicrobials treatment should be started on clinical suspicion. The choice of the drug has to be guided by local pathogen epidemiology and clinical features; in fact, community type pneumonia requires a first-line antimicrobial such as amoxicillin/clavulanic acid. On the contrary, a nosocomial type of infection needs to be treated as a ventilator-associated pneumonia in agreement with published guidelines. Nevertheless, quantitative culture should be obtained in order to de-escalate antimicrobials. In conclusion, aspiration pneumonia is a frequently encountered disease that can be prevented by relatively simple measures.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
重症监护病房吸入性肺炎的预防与治疗。
误吸是重症监护病房院内感染的主要原因。避免或减少误吸的技术对预防肺炎和肺炎很重要。最重要的预防措施包括半卧位,监测肠内喂养,使用促进剂,避免过度镇静。对涉及这些综合征的病原体的分析通常显示厌氧菌的作用很小。在治疗方面,吸入性肺炎不需要任何抗微生物药物;相反,吸入性肺炎必须治疗。应根据临床怀疑开始经验性抗微生物药物治疗。药物的选择应结合当地病原菌流行病学和临床特点;事实上,社区型肺炎需要一线抗微生物药物,如阿莫西林/克拉维酸。相反,根据已公布的指南,医院感染类型需要作为呼吸机相关性肺炎进行治疗。然而,应该进行定量培养,以降低抗菌素的含量。总之,吸入性肺炎是一种常见的疾病,可以通过相对简单的措施加以预防。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Idiopathic Pulmonary Fibrosis Nosocomial pneumonia : rationalizing the approach to empirical therapy. Managing asthma in expectant mothers. New strategies for the treatment of pulmonary hypertension in sickle cell disease : the rationale for arginine therapy. Antioxidant strategies in respiratory medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1